WHO issues antibiotics production guidelines to combat resistance risk
The World Health Organisation (WHO) on Tuesday expressed concern over antibiotics production in many countries.
WHO, in a statement, issued recommendations for the safe production of antibiotics for the first time.
WHO reported that too many active substances from pharmaceutical factories often end up in wastewater and the environment, which could promote the spread of antibiotic-resistant bacteria.
If these bacteria infect humans and cause infections, there are hardly any effective treatments against them.
Antibiotic resistance also develops from the overuse of antibiotics or the premature termination of a treatment cycle.
WHO wastewater specialist Kate Medlicott said the recommendations are aimed particularly at producers.
She said the regulatory authorities should also place higher environmental requirements on the approval of pharmaceutical productions than before.
WHO also recommended full transparency so that investors, buyers and patients could appreciate the environmental protection efforts of pharmaceutical companies.
The organisation also advised patients to be better informed about disposing unused tablets.
“Medication residues do not belong in the toilet or sink/drain,” the German Environment Ministry (BMUV) stated on its website.
